*

COLISTIMATHATE SODIUM

Active substance colistimethate sodium. Inhaled antibiotic 1 MIU/Vial powder for nebulizer solution. Indicated for the treatment by nebulisation of colonisation and infections of the lung due to susceptible Pneudomonas Aeruginosa in patients with Cystic Fibrosis.
Qualitative and Quantitative Composition: Each vial contains 1 million International Units (1 MIU) which is approximately equivalent to 80 mg of Colistimethate Sodium
Pharmaceutical Form:   Powder for nebuliser solution
For use with the I-neb® AAD®
(Advanced Aerosol Delivery) System.

The product is supplied in clear type I glass vials sealed with a siliconised chlorobutyl type I rubber stopper and protected by a 20 mm aluminium tear-off cap incorporating a red flip-up central plastic top. The product is supplied in packs of 30 vials. Each pack contains a Tadim® - Promixin® Disc to enable use with the I-neb® AAD® System.

For further information, please read the SPC.

This medicine is prescribed, so you should follow the instructions of the physician.

* In certain markets outside Greece Tadim is marketed as Promixin.